Excel Venture Management

Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, medical devices, and life science platforms.


The Excel Board of Strategic Advisors ("BSA") is composed of physicians, scientists, business executives, and entrepreneurs who Excel considers to be thought leaders in their fields and invaluable resources for Excel. Members of the BSA assist the Excel team in identifying investment opportunities and in assessing the technical or commercial merits of a technology. The BSA members may also be available to assist portfolio companies in finding solutions to challenges in technology development and in identifying exit opportunities.


Anthony Atala, M.D.
Professor and Chair (Urology) and Director, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine; Co-founder Tengion, Inc.

James Collins, Ph.D.
Boston University Professor; Professor of Biomedical Engineering; Co-Director, Center for BioDynamics, Boston University; MacArthur Foundation "Genius Award"; Co-founder Cellicon

Gregory Critchfield, M.D., M.S.
Former President of Myriad Genetics, Former CMO of Corning Labs (now Quest). Member of Board of Directors of BioTrove, Biocius, and Saladax

John Fallon, M.D.
Retired, former Senior Vice President, Chief Physician Executive of Blue Cross Blue Shield of Massachusetts. Prior to BCBSMA, he was CEO for the clinical enterprise at the State University of New York's Downstate Medical Center. Currently on the board of Exact Sciences (Nasdaq: EXAS), Insulet (Nasdaq: PODD) and Amag Pharma (Nasdaq:Amag).

Steven R. Gullans, Ph.D.
CEO of Gemphire Therapeutics; Former Managing Director, Excel Venture Management; Co-Founder Orionis Biosciences

Jonathan Gruber, Ph.D.
Ford Professor of Economics, MIT; Director, Health Care Program at the National Bureau of Economic Research; President, American Society of Health Economists; Associate Editor Journal of Public Economics

David C. Kiernan, M.D., J.D.
Partner, Williams & Connolly LLP, a leading intellectual property and healthcare attorney in the U.S.

Joseph Loscalzo, M.D., Ph.D.
Professor and Chairman, Physician-in-Chief, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Creagh E. Milford D.O., M.P.H.
President of Population Health Services of Mercy Health, the largest Clinically Integrated Network in Ohio

Gideon Searle
Managing Partner of The Serafin Group LLC, as well as a Director of Kinship Trust Company Family Liaison, The Searle Scholars Program

Adam Singer, M.D.
Retired, former Founder, CSO, Chairman and CEO, IPC The Hospitalist Company

Hamilton Smith, Ph.D.
Nobel Laureate; Founder Celera and Synthetic Genomics

Mervyn Turner, Ph.D.
Former Chief Strategy Officer of Merck & Co., Former Senior Vice President, Emerging Markets, Merck Research Laboratories

J. Craig Venter, Ph.D.
Founder Human Genome Sciences, Celera, Diversa, Synthetic Genomics; Sequenced the human genome